AzTrials
AzTrials

Tourette's DisorderNCT02413216

TicHelper: A Computerized Comprehensive Behavioral Intervention for Tics (CBIT)

A study testing TicHelper and Internet Based Resources in people with Tourette's Disorder and Persistent (Chronic) Motor or Vocal Tic Disorder, run by University of Utah at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Tic Disorders (including Tourette Disorder) are relatively common in school-age children and for some children can lead to significant psychosocial and physical impairment and diminished quality of life. Non-pharmacological treatments have been shown to be effective for reducing tics in some children. Read more about this study

Who is it for?
Ages 8 to 18 years
What is being tested?
TicHelper and Internet Based Resources
Could I receive a placebo?
No, everyone receives an active treatment
How many people
55 participants
Where
2 sitesUnited States
Study dates
Aug 2015to 31 Aug 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Child and parent are English speaking.
  • Child meets diagnostic criteria for Tourette's disorder or persistent (chronic) motor or vocal tic disorder according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders - 5th Edition.
  • Child scores >70 on a brief intelligence test
  • Child currently engages in at least one motor and/or vocal tic multiple times per day
  • Clinician rated tic severity score of > 3 (mildly ill or worse)
  • Child is unmedicated for tics or associated conditions or has been on stable psychotropic medication for at least 6 weeks with no changes or planned changes in dosage.
  • Family has daily access to a personal computer with internet access and software meeting TicHelper minimum system requirements.

Who cannot join

  • A Yale-Global Tic Severity Scale (YGTSS) score > 30
  • Child scores < 70 on intelligence test
  • Child meets diagnostic criteria for substance abuse or dependence or conduct disorder (within past 3 months) according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders - 5th Edition.
  • Current or past non-drug treatment for tics that consisted of 4 or more sessions of habit reversal training or CBIT.
  • Child has lifetime diagnosis of mania or psychotic disorder
  • Child has any serious psychiatric or neurological condition not currently being managed, managed ineffectively, or requiring more immediate treatment other than that provided by the study.

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Marquette University

    Milwaukee, Wisconsin, 53201

  • University of Utah

    Salt Lake City, Utah, 84112

Other trials in United States

About this study

Official title: Creating a Computerized Self-administered Version of Comprehensive Behavioral Intervention for Tics

Tic Disorders (including Tourette Disorder) are relatively common in school-age children and for some children can lead to significant psychosocial and physical impairment and diminished quality of life. Non-pharmacological treatments have been shown to be effective for reducing tics in some children. These treatment options are desired by parents, but are not widely available. The investigators recently developed an online, computerized, self-administered version of CBIT called TicHelper.com. The current study will test the efficacy of TicHelper.com in a randomized clinical trial.

Read the detailed description

Effective non-pharmacological treatment options such as comprehensive behavioral intervention for tics (CBIT) have been shown to be effective for reducing tics in some children with chronic tic disorders, including Tourette's disorder. Although effective, many parents and children do not have access to a provider trained in these therapies and practical barriers such as travel and high costs for ongoing therapy limit treatment dissemination and utilization.The investigators recently developed an online, computerized, self-administered version of CBIT called TicHelper.com. This program is an 8-week online program designed to teach children and families empirically-supported tic management skills. The current study will test the efficacy of TicHelper.com in a randomized clinical trial in which 64 children with Tourette's Disorder or a persistent (chronic) tic disorder will be randomly assigned to 8-weeks of TicHelper.com (N=32) or an 8-week internet resource control condition (N=32). Tic symptoms will be assessed by a condition-blind independent evaluator at baseline, post-treatment, and 1-month follow-up. Information regarding patient acceptability of the program will also be collected. This project will test whether TicHelper.com is an efficacious and acceptable way to teach tic-management skills for children with tics.

Being tested
TicHelper, Internet Based Resources
Keywords
Tic Disorder, Tourette, Motor tic, Vocal tic, Habit reversal training, CBIT, TicHelper, Behavior Therapy
Medical subject headings
Tourette Syndrome, Bronchiolitis Obliterans Syndrome, Tic Disorders, Tics

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TicHelperBehavioural

    Also called Habit Reversal Training, Comprehensive Behavioral Intervention for Tics

    TicHelper.com is an 8-week online program designed to teach tic management skills. Content and activities included in TicHelper.com are based on existing empirically-supported treatments including Habit Reversal Training (HRT) and Comprehensive Behavioral Intervention for Tics (CBIT). TicHelper.com is designed to teach tic management skills including psychoeducation, relaxation training, awareness training, competing response training, and social support. It is also designed to teach patients/parents to recognize and reduce tic-exacerbating reactions and activities.

  • Internet Based ResourcesOther

    The Internet-Based Resources (IBR) condition is designed to provide patients/parents with access to a wide range of educational materials. These materials contain up-to-date information regarding what is known about tic disorders and their management. Materials covering medical, educational, and behavioral/psychological topics are provided.

Study groups in NCT02413216
Study groupRoleWhat they receive
TicHelperExperimentalIn this condition, participants will be provided with a secure username and login information for TicHelper.com. Participants will be asked to log in and use TicHelper.com for 8 weeks as instructed by the program (TicHelper recommends 30-60 minutes of website and therapeutic activity per day). TicHelper.com consists of 3 modules: Education, Assessment, and Intervention. The education module provides information about tic disorders and treatment. The assessment module tracks progress through the program. The intervention module uses interactive activities to teach tic management skills including habit reversal training (HRT). During HRT, patients learn to become more aware of tics and pre-tic sensations and to subsequently interrupt tics. Participants will also learn ways to interact with each other regarding tics, to identify and alter tic-worsening factors, and relaxation strategies to reduce stress.
Receives: Behavioral: TicHelper
Internet-Based Resources ConditionActive comparatorParticipants who are assigned to the Internet-Based Resources (IBR) condition will receive a collection of materials with inks to the best available online resources about tic disorders and their treatment. The sites that are provided use a variety of online print, video, and animation materials to teach patients about various aspects of chronic tic disorders and their management. Participants will will be asked to explore and use the website information over the course of 8 weeks in any manner they find helpful. Participants will be asked to spend 30-60 minutes per day reviewing and discussing the information provided.
Receives: Other: Internet Based Resources

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in the Total Tic Severity Score on the Yale Global Tic Severity Scale (YGTSS)

    Clinician interview to assess overall severity of tics

    Measured: Baseline, Week 8 (post-treatment), Week 12 (1-month follow-up)

Secondary outcomes (3)
  1. Change in overall tic severity on the Clinician Global Impressions-Severity Scale

    Measures clinician's impression of overall severity

    Measured: Baseline, Week 8 (post-treatment), Week 12 (1-month follow-up)

  2. Clinician Global Impressions-Improvement Scale

    Measures clinician's impression of improvement since starting treatment

    Measured: Week 8 (post-treatment)

  3. Clinician Global Impressions- Improvement Scale

    Measures clinician's impression of improvement since starting treatment

    Measured: Week 12 (1-month follow-up)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Apr 2015 (estimated)
  2. Study startAug 2015
  3. Primary completion1 Jun 2017
  4. Study completion31 Aug 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
55 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02413216
Sponsor's protocol ID
2R44MH096344-02
Status last verified
Dec 2017
First submitted
1 Apr 2015
Last updated
18 Dec 2017
Results posted
No
Data monitoring committee
No

Publications

  • Piacentini J, Woods DW, Scahill L, Wilhelm S, Peterson AL, Chang S, Ginsburg GS, Deckersbach T, Dziura J, Levi-Pearl S, Walkup JT. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA. 2010 May 19;303(19):1929-37. doi: 10.1001/jama.2010.607.

    PubMed 20483969
  • Woods DW, Piacentini JC, Scahill L, Peterson AL, Wilhelm S, Chang S, Deckersbach T, McGuire J, Specht M, Conelea CA, Rozenman M, Dzuria J, Liu H, Levi-Pearl S, Walkup JT. Behavior therapy for tics in children: acute and long-term effects on psychiatric and psychosocial functioning. J Child Neurol. 2011 Jul;26(7):858-65. doi: 10.1177/0883073810397046. Epub 2011 May 9.

    PubMed 21555779
  • Jakubovski E, Reichert C, Karch A, Buddensiek N, Breuer D, Muller-Vahl K. The ONLINE-TICS Study Protocol: A Randomized Observer-Blind Clinical Trial to Demonstrate the Efficacy and Safety of Internet-Delivered Behavioral Treatment for Adults with Chronic Tic Disorders. Front Psychiatry. 2016 Jun 30;7:119. doi: 10.3389/fpsyt.2016.00119. eCollection 2016.

    PubMed 27445874

Questions about this trial

What is this clinical trial studying?

A study testing TicHelper and Internet Based Resources in people with Tourette's Disorder and Persistent (Chronic) Motor or Vocal Tic Disorder, run by University of Utah at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Dec 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in the Total Tic Severity Score on the Yale Global Tic Severity Scale (YGTSS) (time frame: Baseline, Week 8 (post-treatment), Week 12 (1-month follow-up)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02413216, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Dec 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in